KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Cantrixil Study, page-4

  1. Rich&Poor
    1,161 Posts.
    lightbulb Created with Sketch. 859
    clock Created with Sketch.
    26/09/19
    23:14
    Post #: 40597337
    Hi Harvett, it could have a connection to the ESMO data presentation this weekend, as mentioned in Kazia September 2019 Investors Newsletter.

    "Meanwhile, the Cantrixil phase I study has been progressing extremely well and is now close to completion, with completion expected in the first half of next year. New data will be reported at the upcoming ESMO conference in late September, and this should help to provide further insight into the potential efficacy of Cantrixil."

    Regards.
    KZA Price at posting: 52.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HYT Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep
right-arrow Created with Sketch.
NEWS Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip
right-arrow Created with Sketch.
FMG FMG reports third highest earnings in history on strong iron ore sales
right-arrow Created with Sketch.
EBR EBR reaches review milestone for wireless cardiac pacing device
right-arrow Created with Sketch.
HVN Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.